To be considered for inclusion on to the Pharmaceutical Benefits Scheme (PBS), the product must first be registered and approved for use by the TGA. To get approval by the TGA, a company has to submit many clinical trials that take years to complete. Some clinical trials for medicinal cannabis products are underway, but they are many years away from having enough data for a TGA submission.
Cannabis Access Clinics fees are NET of medicare rebates and cover our consultation costs and the administrative costs of applying for approval and monitoring patient progress.
Cannabis Access Clinics charges an out-of-pocket fee of $80 for screening for our doctor to assess the suitability of the patient for medicinal cannabis. If the doctor decides to proceed with an application then the patient will be advised of what documentation is required in order to proceed and a follow-up consultation arranged. This follow-up consultation will allow for the Cannabis Access Clinics doctor to confirm received documentation is correct, obtain additional patient information and initiate the application to the TGA. The follow-up consultation will cost $120. An admin fee of $250 is payable after the follow-up consultation. This covers the associated costs of application to the TGA and the associated back-office administrative duties.
If the application to the TGA is approved then the patient will require a post-approval consultation with a Cannabis Access Clinic doctor to discuss their medication, prescription and dosage details. The post-approval consultation will cost $120. Monitoring consultations will be an out-of-pocket cost of $80 respectively. We request a 50% deposit from you at the time of booking.